The Pharma Letter

FDA extends review of Sanofi’s tolebrutinib for progressive multiple sclerosis

The American medicines regulator has delayed its decision on Sanofi’s (Euronext: SAN) tolebrutinib, an oral Bruton's tyrosine ...

Goodfin and NYU Stern Professor Srikanth Jagabathula Release Landmark Study Showing AI Models Perform at a Level Above and Beyond the CFA Level III Exam Standards

Goodfin, the AI wealth platform for exclusive private market investments, has released groundbreaking research led by Shilpi Nayak, Co-Founder & CTO of Goodfin, in collaboration with NYU Stern's ...

How Google’s Gemma 3 is Redefining AI and Human Interaction

Discover Google’s Gemma 3, a groundbreaking multimodal AI transforming education, accessibility, and creativity with human-like intelligence.